Matthew G. Kaag, MD - Penn State Cancer Institute
Researcher Profile
Matthew G. Kaag, MD
Associate Professor, Department of Urology
Associate Professor, Department of Surgery
Associate Professor, Department of Surgery
Scientific Program:Cancer Control
Disease Teams:
Cancer Institute, Genitourinary Cancer Team
Clinical Trials
A Phase II/III trial of Durvalumab and Chemotherapy for Patients with High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy EA8192
A Phase 2 Multi-Arm, Multi Cohort, Open Label Study To Evaluate The Safety And Efficacy Of Cretostemogene Grenadenorepvec In Participants With High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)
Recent Publications
2025
Chowdhury, D, Apolo, AB, Jiang, DM, Skinner, EC, Chisolm, S, Bangs, R, Maganti, M, Steinberg, GD, Kaag, M, Efstathiou, JA & Sridhar, SS 2025, 'Understanding patient perspectives in the management of their muscle-invasive bladder cancer', BJU International, vol. 136, no. 3, pp. 493-499. https://doi.org/10.1111/bju.16695
2024
Segel, JE, Wong, WG, Kaag, M, Joshi, M, Warrick, J, Lengerich, EJ & Shen, C 2024, 'Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer', Urology Practice, vol. 11, no. 2, pp. 339-346. https://doi.org/10.1097/UPJ.0000000000000503
2023
Joshi, M, Tuanquin, L, Zhu, J, Walter, V, Schell, T, Kaag, M, Kilari, D, Liao, J, Holder, SL, Emamekhoo, H, Sankin, A, Merrill, S, Zheng, H, Warrick, J, Hauke, R, Gartrel, B, Stein, M, Drabick, J, Degraff, DJ & Zakharia, Y 2023, 'Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: Results from phase II study, BTCRC-GU15-023', Journal for ImmunoTherapy of Cancer, vol. 11, no. 2, e006551. https://doi.org/10.1136/jitc-2022-006551
Fuletra, J, Rjepaj, C, Clark, JY, Knoedler, JJ, MacDonald, SM, Kaag, MG, Merrill, SB & Raman, JD 2023, 'Significant Bleeding Complications Following Transrectal Prostate Needle Biopsy: Incidence, Predictors, and Management', Urology Practice, vol. 10, no. 1, pp. 6-8. https://doi.org/10.1097/UPJ.0000000000000349
2022
Warrick, JI, Hu, W, Yamashita, H, Walter, V, Shuman, L, Craig, JM, Gellert, LL, Castro, MAA, Robertson, AG, Kuo, F, Ostrovnaya, I, Sarungbam, J, Chen, YB, Gopalan, A, Sirintrapun, SJ, Fine, SW, Tickoo, SK, Kim, K, Thomas, J, Karan, N, Gao, SP, Clinton, TN, Lenis, AT, Chan, TA, Chen, Z, Rao, M, Hollman, TJ, Li, Y, Socci, ND, Chavan, S, Viale, A, Mohibullah, N, Bochner, BH, Pietzak, EJ, Teo, MY, Iyer, G, Rosenberg, JE, Bajorin, DF, Kaag, M, Merrill, SB, Joshi, M, Adam, R, Taylor, JA, Clark, PE, Raman, JD, Reuter, VE, Chen, Y, Funt, SA, Solit, DB, DeGraff, DJ & Al-Ahmadie, HA 2022, 'Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation (Nature Communications, (2022), 13, 1, (6575), 10.1038/s41467-022-34251-3)', Nature communications, vol. 13, no. 1, 7920. https://doi.org/10.1038/s41467-022-35644-0
Loloi, J, Eccles, JM, Owens, G, Lehman, E, Kaag, MG, Raman, JD & Merrill, SB 2022, 'Diagnostic Imaging in Low-Risk Prostate Cancer: More Harm Than Good?', Urology Practice, vol. 9, no. 2, pp. 135-139. https://doi.org/10.1097/UPJ.0000000000000288
Warrick, JI, Hu, W, Yamashita, H, Walter, V, Shuman, L, Craig, JM, Gellert, LL, Castro, MAA, Robertson, AG, Kuo, F, Ostrovnaya, I, Sarungbam, J, Chen, YB, Gopalan, A, Sirintrapun, SJ, Fine, SW, Tickoo, SK, Kim, K, Thomas, J, Karan, N, Gao, SP, Clinton, TN, Lenis, AT, Chan, TA, Chen, Z, Rao, M, Hollman, TJ, Li, Y, Socci, ND, Chavan, S, Viale, A, Mohibullah, N, Bochner, BH, Pietzak, EJ, Teo, MY, Iyer, G, Rosenberg, JE, Bajorin, DF, Kaag, M, Merrill, SB, Joshi, M, Adam, R, Taylor, JA, Clark, PE, Raman, JD, Reuter, VE, Chen, Y, Funt, SA, Solit, DB, DeGraff, DJ & Al-Ahmadie, HA 2022, 'FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation', Nature communications, vol. 13, no. 1, 6575. https://doi.org/10.1038/s41467-022-34251-3
Hull, BP, Humphrey, MD, Lehman, KK, Kaag, MG, Merrill, SB & Raman, JD 2022, 'Impact of an inpatient advanced practice provider on hospital length of stay after major urologic oncology procedures', Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 9, pp. 411.e19-411.e25. https://doi.org/10.1016/j.urolonc.2022.06.020
Strausser, SA, Owens, RG, Vu, T, Kwok, E, Schaefer, EW, Boltz, S, Aminsharifi, A, Kaag, M, Raman, JD & Merrill, SB 2022, 'Patient Perceptions Regarding Routine Oncologic Follow-Up for Urologic Malignancies', Clinical Genitourinary Cancer, vol. 20, no. 3, pp. 298-298.e11. https://doi.org/10.1016/j.clgc.2022.01.014